Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12442)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 27, 2019 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Laborda TJ, Jensen MK, Kavan M, Deneau M. Treatment of primary sclerosing cholangitis in children. World J Hepatol 2019; 11(1): 19-36 [PMID: 30705716 DOI: 10.4254/wjh.v11.i1.19] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v11/i1/19.htm |
| Number | Citing Articles |
| 1 |
Rebecca Little, Binita M. Kamath, Amanda Ricciuto. Pediatric Inflammatory Bowel Disease. 2023; : 129 doi: 10.1007/978-3-031-14744-9_11
|
| 2 |
Binita M. Kamath, Philip Stein, Roderick H. J. Houwen, Henkjan J. Verkade. Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis. Liver International 2020; 40(8): 1812 doi: 10.1111/liv.14553
|
| 3 |
Johanna Eliasson, Bobby Lo, Christoph Schramm, Olivier Chazouilleres, Trine Folseraas, Ulrich Beuers, Henriette Ytting. Survey uncovering variations in the management of primary sclerosing cholangitis across Europe. JHEP Reports 2022; 4(11): 100553 doi: 10.1016/j.jhepr.2022.100553
|
| 4 |
Cynthia W. Buness, Kevin M. Johnson, Ahmad Hassan Ali, Leina Alrabadi, Keith D. Lindor, Tamir Miloh, Kenneth L. Cox. Successful response of primary sclerosing cholangitis and associated ulcerative colitis to oral vancomycin may depend on brand and personalized dose: report in an adolescent. Clinical Journal of Gastroenterology 2021; 14(2): 684 doi: 10.1007/s12328-020-01296-0
|
| 5 |
Chad Gwaltney, Stephanie Bean, Meredith Venerus, Lisa Karlsson, Natalie Warholic, Lise Kjems, Patrick Horn. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases. Advances in Therapy 2022; 39(11): 5126 doi: 10.1007/s12325-022-02261-8
|
| 6 |
Trevor J. Laborda, Amanda Ricciuto, Madeleine Aumar, Nicholas Carman, Matthew DiGuglielmo, Laura G. Draijer, Katryn N. Furuya, Nitika Gupta, Bart G.P. Koot, Kathleen M. Loomes, Ellina Lytvyak, Mercedes Martinez, Tamir Miloh, Aldo J. Montano‐Loza, Emily R. Perito, Pushpa Sathya, Uzma Shah, Eyal Shteyer, Ruchi Singh, Amy Taylor, Pamela L. Valentino, Bernadette Vitola, Melissa Zerofsky, Andréanne Zizzo, Mark R. Deneau. Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(4): 459 doi: 10.1097/MPG.0000000000002855
|
| 7 |
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 2022; 77(3): 761 doi: 10.1016/j.jhep.2022.05.011
|
| 8 |
Sabina Wiecek, Alicja Wojtyniak, Barbara Pindur, Magdalena Machnikowska-Sokołowska, Katarzyna Gruszczyńska, Urszula Grzybowska-Chlebowczyk. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population—Single Center Study. Medicina 2021; 57(7): 663 doi: 10.3390/medicina57070663
|
| 9 |
Maryam Haider, Abdalaziz Awadelkarim, Huyam Awadalla, Tooba Tariq, Bashar Mohamad. Primary Sclerosing Cholangitis in a Paediatric Patient: An Atypical Presentation. EMJ Hepatology 2022; doi: 10.33590/emjhepatol/21-00172
|
| 10 |
Martin Walter Laass, Josefine Ziesmann, Jan de Laffolie, Nadja Röber, Karsten Conrad. Anti‐Proteinase 3 Antibodies as a Biomarker for Ulcerative Colitis and Primary Sclerosing Cholangitis in Children. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(4): 463 doi: 10.1097/MPG.0000000000003359
|
| 11 |
Sabina Wiecek. Hepatitis A and Other Associated Hepatobiliary Diseases. 2020; doi: 10.5772/intechopen.90714
|
| 12 |
Sarah Kemme, Cara L. Mack. Pediatric Autoimmune Liver Diseases. Pediatric Clinics of North America 2021; 68(6): 1293 doi: 10.1016/j.pcl.2021.07.006
|
| 13 |
Wei Du, Weili Han, Jiaqiang Dong. Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis. Medical Hypotheses 2020; 144: 110211 doi: 10.1016/j.mehy.2020.110211
|
| 14 |
Sabina Wiecek. Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy. 2022; doi: 10.5772/intechopen.102080
|
| 15 |
Eva Vlčková, Katarína Mitrová. Sclerosing cholangitis in children with inflammatory bowel disease. Česko-slovenská pediatrie 2023; 78(3): 182 doi: 10.55095/CSPediatrie2023/025
|
| 16 |
Kathleen M. Loomes, Karan McBride Emerick. Pediatric Gastrointestinal and Liver Disease. 2021; : 769 doi: 10.1016/B978-0-323-67293-1.00070-0
|
| 17 |
A. A. Kamalova, A. R. Gaifutdinova, A. A. Malov, E. R. Safina, R. A. Nizamova, L. I. Basanova. Primary schlerosing cholangitis in children with inflammatory bowel disease. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(5): 150 doi: 10.21508/1027-4065-2021-66-5-150-156
|
| 18 |
Hassan Aboughalia, Helen HR Kim, Andre A.S. Dick, M. Cristina Pacheco, Robert E. Cilley, Ramesh S. Iyer. Pediatric biliary disorders: Multimodality imaging evaluation with clinicopathologic correlation. Clinical Imaging 2021; 75: 34 doi: 10.1016/j.clinimag.2021.01.006
|
| 19 |
Anna L. Rundle, Nicole Baron, Rita Marie John. Pediatric Diagnostic Labs for Primary Care: An Evidence-based Approach. 2022; : 319 doi: 10.1007/978-3-030-90642-9_9
|
| 20 |
Pierre Russo, Elizabeth Rand, Kathleen M. Loomes. Pathology of Pediatric Gastrointestinal and Liver Disease. 2024; : 423 doi: 10.1007/978-3-031-62589-3_10
|
| 21 |
Petr Jabandziev, Tatsuhiko Kakisaka, Julia Bohosova, Tereza Pinkasova, Lumir Kunovsky, Ondrej Slaby, Ajay Goel. MicroRNAs in Colon Tissue of Pediatric Ulcerative Pancolitis Patients Allow Detection and Prognostic Stratification. Journal of Clinical Medicine 2021; 10(6): 1325 doi: 10.3390/jcm10061325
|
| 22 |
Elif Ozdogan, Cigdem Arikan. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy. Clinical and Experimental Pediatrics 2023; 66(3): 110 doi: 10.3345/cep.2022.00367
|
| 23 |
Ryan T. Fischer, J. Christopher Day, Heather Wasserkrug, Megan Faseler, Alexander Kats, James F. Daniel, Voytek Slowik, Walter Andrews, Richard J. Hendrickson. Complications of Cryptosporidium infection after pediatric liver transplantation: Diarrhea, rejection, and biliary disease. Pediatric Transplantation 2020; 24(8) doi: 10.1111/petr.13807
|
| 24 |
Amala J. Alenchery, Sophia Patel, Lori Mahajan, Jacob A. Kurowski, Sarah Worley, Vera Hupertz, Kaddakal Radhakrishnan, Mohammad Nasser Kabbany. Single Center Experience of Oral Vancomycin Therapy in Young Patients with Primary Sclerosing Cholangitis: A Case Series. Livers 2023; 3(1): 93 doi: 10.3390/livers3010009
|
| 25 |
Nedim Hadžić, Marianne Samyn. Liver Disease in Adolescence. In Clinical Practice 2022; : 129 doi: 10.1007/978-3-030-98808-1_8
|
| 26 |
Tej I Mehta, Simcha Weissman, Brian M Fung, James H Tabibian. Geoepidemiologic variation in outcomes of primary sclerosing cholangitis. World Journal of Hepatology 2020; 12(4): 116-124 doi: 10.4254/wjh.v12.i4.116
|
| 27 |
M. Carbone, A. Della Penna, C. Mazzarelli, E. De Martin, C. Villard, A. Bergquist, P. D. Line, J. M. Neuberger, S. Al-Shakhshir, P. J. Trivedi, U. Baumann, L. Cristoferi, J. Hov, B. Fischler, N. H. Hadzic, D. Debray, L. D’Antiga, N. Selzner, L. S. Belli, S. Nadalin. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement. Transplant International 2023; 36 doi: 10.3389/ti.2023.11729
|